- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cancers on ultrasound elude CAD
Researchers from Seoul National University Medical Center found that ultrasound-only-detected breast cancers are not very sensitive to a mammography computer-aided detection system.
Researchers from Seoul National University Medical Center found that ultrasound-only-detected breast cancers are not very sensitive to a mammography computer-aided detection system.
Dr. Sang Kyu Yang and colleagues applied CAD to 96 bilateral mammograms obtained on a full-field digital system. The patient population consisted of 26 women with 29 ultrasound-detected cancers (all normal on mammography) and 70 women with 70 mammography-detected cancers. Patients in the latter group had negative findings at clinical exam.
In the ultrasound group, CAD produced 17 marks on masses and five on calcifications, correctly identifying six masses. The false-positive rate was 0.15 per image and 0.62 per case.
In the mammography group, the CAD system scored 116 marks on masses and 185 on calcifications, resulting in 58 and 139 true positives, respectively. The false-positive rate was 0.37 per image and 1.48 per case.
The sensitivity of CAD, based on radiologic primary features, was 17% for the ultrasound-detected cancers and 96% for the mammography-detected cancers. This information may be useful when applying CAD to screening mammography and adjunct ultrasound to detect early breast cancers, according to the researchers, who presented their work in a poster presentation at the 2005 Radiological Society of North America meeting.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
FDA Clears AI-Powered Cardiovascular Ultrasound System from Siemens Healthineers
August 13th 2024Offering a variety of AI features for streamlined workflow and enhanced visualization, the Acuson Origin ultrasound system also features the newly FDA-cleared AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.
